Ingevity Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw strong growth across all segments (excluding divested units), with adjusted EBITDA up 14% and margins expanding to 36.6%. Full-year guidance was raised for EBITDA, EPS, and free cash flow, supported by robust demand, portfolio transformation, and disciplined capital allocation.
-
The company has nearly completed its portfolio transformation, focusing on high-margin Performance Materials and Pavement Technologies. Growth is driven by innovation, regulatory tailwinds, and expansion into filtration, with strong financial discipline and updated targets expected next year.
-
Q1 2026 saw 4% sales growth, strong EBITDA margins, and accelerated share repurchases, driven by portfolio simplification and robust Performance Materials results. Guidance for 2026 is reaffirmed, with continued focus on debt reduction and share buybacks.
-
The meeting saw the election of nine directors and approval of all shareholder proposals. 2025 financials showed strong free cash flow and improved debt metrics, with plans to generate $1 billion in deployable cash over two years. No questions were raised by stockholders.
-
The company is undergoing a major transformation, divesting non-core assets and focusing on two highly profitable segments: Performance Materials and Pavement Technologies. With $1 billion in deployable cash expected over two years, priorities include organic growth, debt reduction, and share repurchases.
Fiscal Year 2025
-
Adjusted EBITDA grew 10% to $398M with margins above 30%, despite an 8% sales decline and $167M GAAP net loss due to special charges. Free cash flow hit $274M, leverage dropped to 2.6x, and 2026 guidance projects stable margins and continued share buybacks.
-
A streamlined portfolio will focus on Performance Materials and Pavement Technologies, targeting high margins and stable growth. Nearly $1 billion in deployable cash will be used for organic growth, debt reduction, and share repurchases, with double-digit EPS growth expected.
-
Q3 saw strong margin expansion and cash flow, with record Road Technologies sales and robust performance materials. The $110M industrial specialties divestiture will fund debt reduction, and full-year guidance was narrowed due to tariff and demand headwinds.
-
Q2 saw improved profitability and cash flow despite a 7% sales decline, with EBITDA margin rising to 30.1% and net leverage reduced to 3x. Raised full-year EBITDA and free cash flow guidance, advanced asset sales, and continued portfolio review amid ongoing macroeconomic and tariff uncertainties.
-
First quarter results showed strong margin and EBITDA improvement despite a 17% sales decline, driven by portfolio repositioning and cost actions. Guidance was widened to reflect a 10% drop in North American auto production, but profitability and leverage targets were reaffirmed.
Fiscal Year 2024
-
2024 saw improved margins and record results in Performance Materials, offset by a sharp decline in Performance Chemicals due to strategic repositioning. Strong free cash flow and debt reduction were achieved, with 2025 guidance targeting further margin strength and lower leverage.
-
Sales declined 16% year-over-year due to repositioning and weather impacts, but gross margin and EBITDA margin improved significantly. Performance Materials and APT segments showed resilience, while Performance Chemicals benefited from strategic exits and cost savings. Guidance remains cautious amid weak industrial demand.
-
Q2 2024 saw major restructuring in Performance Chemicals, including a costly CTO contract termination and facility closure, leading to a $283.7 million net loss. Performance Materials delivered record margins, while full-year guidance was revised downward amid ongoing market and weather challenges.